Blueprint Genetics

Blueprint Genetics aims to develop different types of gene sequencing products based on the CLINT artificial intelligence platform and its proprietary targeted sequencing technology, OS-Seq. Its clinical-grade NGS panels cover more than 2,200 diseases across multiple fields, including cardiology, ophthalmology, hematology, neurology, and immunology.